CDK1 Serves As a Novel Therapeutic Target for Endometrioid Endometrial Cancer

Overview

Journal J Cancer

Specialty Oncology

Date 2021 Mar 24

PMID 33758599

Citations 15

Authors

Xue Ying

Xuan Che

Jianzhang Wang

Gen Zou

Qin Yu

Xinmei Zhang

Affiliations

Soon will be listed here.

Abstract

Endometrial cancer (EC) is one of the most common and prevalent gynecologic malignancies worldwide. The aim of this study was to identify a novel therapeutic target for endometrioid endometrial cancer. Bioinformatic analysis was performed and CDK1 was screen out as one of the hub genes in the pathogenesis of EC. Immunohistochemistry was used to verify the expression of CDK1 in endometrial cancer tissue. Cell viability and colony formation were used to study the effects of CDK1 on the proliferation and colony formation of endometrial cancer cells . Apoptosis and cell cycle assays were used to elucidate the mechanism of CDK1 affecting cell proliferation. Tumor xenograft transplantation assay was performed to show the effects of CDK1 on the growth of endometrial cancer cells . CDK1 was over expressed in endometrioid endometrial cancer, and accumulation of cytoplasmic CDK1 was associated with histological grade of EC. CDK1 promoted endometrial cancer cell growth and colony formation . The inhibition of CDK1 activity induced cell apoptosis and caused G2/M phase arrest of cell cycle in endometrial cancer cells. The inhibition of CDK1 activity also inhibited endometrial cancer growth in xenograft models. CDK1 was involved in the pathogenesis of endometrioid endometrial cancer and provided a novel therapeutic target for endometrioid endometrial cancer.

Citing Articles

PTPN11 is a potential biomarker for type 2 diabetes mellitus complicated with colorectal cancer.

Sun M, Han Z, Luo Z, Ge L, Zhang X, Feng K Sci Rep. 2024; 14(1):25155.

PMID: 39448762 PMC: 11502912. DOI: 10.1038/s41598-024-75889-x.

Discovery of Potential Inhibitors of CDK1 by Integrating Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation Studies, and Evaluation of Their Inhibitory Activity.

Teotia V, Jha P, Chopra M ACS Omega. 2024; 9(38):39873-39892.

PMID: 39346877 PMC: 11425824. DOI: 10.1021/acsomega.4c05414.

miR-200a-3p promotes the malignancy of endometrial carcinoma through negative regulation of epithelial-mesenchymal transition.

Ma Y, Wang Y, Wang C, Wang Y, Hu J, Zhang Z Discov Oncol. 2024; 15(1):243.

PMID: 38916621 PMC: 11199454. DOI: 10.1007/s12672-024-01106-w.

CDK1 promotes the phosphorylation of KIFC1 to regulate the tumorgenicity of endometrial carcinoma.

Lin X, He Y, Liu Y, Zhou H, Xu X, Xu J J Gynecol Oncol. 2024; 35(5):e68.

PMID: 38456590 PMC: 11390247. DOI: 10.3802/jgo.2024.35.e68.

Bioinformatics-based Identification of Ferroptosis-related Genes and their Diagnostic Value in Gestational Diabetes Mellitus.

Lv X, An Y Endocr Metab Immune Disord Drug Targets. 2024; 24(14):1611-1621.

PMID: 38347799 DOI: 10.2174/0118715303275367240103102801.

References

Liu L, Lin J, He H . Identification of Potential Crucial Genes Associated With the Pathogenesis and Prognosis of Endometrial Cancer. Front Genet. 2019; 10:373. PMC: 6499025. DOI: 10.3389/fgene.2019.00373. View

Piao J, Zhu L, Sun J, Li N, Dong B, Yang Y . High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma. Gene. 2019; 701:15-22. DOI: 10.1016/j.gene.2019.02.081. View

Chohan T, Qayyum A, Rehman K, Tariq M, Akash M . An insight into the emerging role of cyclin-dependent kinase inhibitors as potential therapeutic agents for the treatment of advanced cancers. Biomed Pharmacother. 2018; 107:1326-1341. DOI: 10.1016/j.biopha.2018.08.116. View

Ni K, Sun G . The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics. Math Biosci Eng. 2019; 16(6):7671-7687. DOI: 10.3934/mbe.2019384. View

Depowski P, Brien T, Sheehan C, Stylos S, Johnson R, Ross J . Prognostic significance of p34cdc2 cyclin-dependent kinase and MIB1 overexpression, and HER-2/neu gene amplification detected by fluorescence in situ hybridization in breast cancer. Am J Clin Pathol. 1999; 112(4):459-69. DOI: 10.1093/ajcp/112.4.459. View

MIKUTA J . International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988. Cancer. 1993; 71(4 Suppl):1460-3. DOI: 10.1002/cncr.2820710409. View

Zhang W, Chen J, Aguilera-Barrantes I, Shiau C, Sheng X, Wang L . Urolithin A suppresses the proliferation of endometrial cancer cells by mediating estrogen receptor-α-dependent gene expression. Mol Nutr Food Res. 2016; 60(11):2387-2395. PMC: 5144574. DOI: 10.1002/mnfr.201600048. View

van Dam P, van Dam P, Rolfo C, Giallombardo M, Van Berckelaer C, Trinh X . In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment. Oncotarget. 2015; 7(3):2780-95. PMC: 4823071. DOI: 10.18632/oncotarget.6667. View

Nurse P . Nobel Lecture. Cyclin dependent kinases and cell cycle control. Biosci Rep. 2003; 22(5-6):487-99. DOI: 10.1023/a:1022017701871. View

10.

Kang J, Sergio C, Sutherland R, Musgrove E . Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells. BMC Cancer. 2014; 14:32. PMC: 3903446. DOI: 10.1186/1471-2407-14-32. View

11.

Whittaker S, Mallinger A, Workman P, Clarke P . Inhibitors of cyclin-dependent kinases as cancer therapeutics. Pharmacol Ther. 2017; 173:83-105. PMC: 6141011. DOI: 10.1016/j.pharmthera.2017.02.008. View

12.

Bokhman J . Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983; 15(1):10-7. DOI: 10.1016/0090-8258(83)90111-7. View

13.

Hartwell L . Nobel Lecture. Yeast and cancer. Biosci Rep. 2003; 22(3-4):373-94. DOI: 10.1023/a:1020918107706. View

14.

Lee J, Kim J, Ahn J, Lee K, Baek N, Choi J . Jaceosidin, isolated from dietary mugwort (Artemisia princeps), induces G2/M cell cycle arrest by inactivating cdc25C-cdc2 via ATM-Chk1/2 activation. Food Chem Toxicol. 2013; 55:214-21. DOI: 10.1016/j.fct.2012.12.026. View

15.

Brooks R, Fleming G, Lastra R, Lee N, Moroney J, Son C . Current recommendations and recent progress in endometrial cancer. CA Cancer J Clin. 2019; 69(4):258-279. DOI: 10.3322/caac.21561. View

16.

Xi Q, Huang M, Wang Y, Zhong J, Liu R, Xu G . The expression of CDK1 is associated with proliferation and can be a prognostic factor in epithelial ovarian cancer. Tumour Biol. 2015; 36(7):4939-48. DOI: 10.1007/s13277-015-3141-8. View

17.

Crusz S, Miller R . Targeted therapies in gynaecological cancers. Histopathology. 2019; 76(1):157-170. DOI: 10.1111/his.14009. View

18.

Castedo M, Perfettini J, Roumier T, Kroemer G . Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ. 2002; 9(12):1287-93. DOI: 10.1038/sj.cdd.4401130. View

19.

Yang W, Cho H, Shin H, Chung J, Kang E, Lee E . Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer. Oncotarget. 2016; 7(31):49481-49497. PMC: 5226523. DOI: 10.18632/oncotarget.10373. View

20.

Murali R, Soslow R, Weigelt B . Classification of endometrial carcinoma: more than two types. Lancet Oncol. 2014; 15(7):e268-78. DOI: 10.1016/S1470-2045(13)70591-6. View